Diagnostic and prognostic factors in patients with prostate cancer: a systematic review

• Mieke Van Hemelrijck,
• Muhammad Imran Omar,
• Jihong Zong,
• Katharina Beyer,
• Lisa Moris,
• Michael Lardas,
• Anna Haire,
• Francesco Barletta,
• Simone Scuderi,
• Eleni Vradi,
• Giorgio Gandaglia,
• Steven MacLennan,
• Bahman Farahmand,
• Sara J Maclennan,
• Zsuzsanna Devecseri,
• Alex Asiimwe,
• Laurence Collette,
• Anders Bjartell,
• James Ndow,
• Alberto Briganti,
• Thomas Van den Broeck,
• Riccardo Campi,
• Isabella Greco,
• Mauro Gacci,
• Megan Molnar,
• Ronald Herrera,
• Monique J Roobol,
• Abdul Rauf,
• Kirill Shiranov,
• Saeed Dabestani,
• Sujenthiran Arun

Affiliations

Mieke Van Hemelrijck

Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UK

Muhammad Imran Omar

Academic Urology Unit/Cochrane Incontinence Group, University of Aberdeen, Aberdeen, UK

Jihong Zong

3 Epidemiology, Bayer U.S. Whippany, New Jersey, USA

Katharina Beyer

King`s College London – Strand Campus, London, London, UK

Lisa Moris

Department of Urology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium

Michael Lardas

Department of Urology, Metropolitan Hospital Athens, Athens, Attike, Greece

Anna Haire

School of Cancer and Pharmaceutical Sciences, King`s College London, London, UK

Francesco Barletta

Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy

Simone Scuderi

Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy

Eleni Vradi

Medical Affairs and PV, Bayer Pharma AG, Berlin, Germany

Giorgio Gandaglia

Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy

Steven MacLennan

Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK

Bahman Farahmand

Global Epidemiology, Bayer AG, Stockholm, Sweden

Sara J Maclennan

Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK

Zsuzsanna Devecseri

Sanofi SA, Paris, Île-de-France, France

Alex Asiimwe

Medical Affairs and PV, Bayer Pharma AG, Berlin, Germany

Laurence Collette

EORTC, Brussels, Belgium

Anders Bjartell

Skåne University Hospital, Malmö, Sweden

James Ndow

Guidelines Office, European Association of Urology, Arnhem, Netherlands

Alberto Briganti

Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IBCAS San Raffaele Scientific Institute, Milan, Lombardia, Italy

Thomas Van den Broeck

Department of Urology, University Hospitals Leuven, Leuven, Belgium

Riccardo Campi

Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy

Isabella Greco

Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy

Mauro Gacci

Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy

Megan Molnar

Bayer AG, Berlin, Germany

Ronald Herrera

1 Occupational and Environmental Epidemiology and NetTeaching Unit, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital Munich (LMU), Munich, Germany

Monique J Roobol

Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands

Abdul Rauf

Department of Pediatrics, Baby Memorial Hospital, Calicut, Kerala, India

Kirill Shiranov

CDC Zdorovie, Rostov-on-Don, Russia

Saeed Dabestani

Dept. of Translational Medicine, Division of Urological Cancers, Lund University, Kristianstad Central Hospital, Malmo, Sweden

Sujenthiran Arun

Flatiron Health, London, UK